biosimilars

4 min read 2022-11-22 18:06:17

Generic drugmakers Teva and Sandoz make major push to biosimilars

Generic drugmakers Teva and Sandoz make major push to biosimilars By Natalie Grover and Steven Scheer Nov 22 (Reuters) – Generic drug makers Teva

2 min read 2022-10-11 22:02:37

ImmunityBio backslides while Rigel and Amneal also reveal job cuts Published: Oct 11, 2022 By Alex Keown BioSpace Ten months after taking over a

17 min read 2022-10-11 16:15:54

Amgen is equipped with a broad and diverse product portfolio, commercial capabilities, and levers for delivering mid-single digit revenue growth over

22 min read 2022-10-11 13:00:54

A separation of Sandoz via a 100 percent spin-off will create the leading European generics company and a global leader in biosimilars, and a more

19 min read 2022-10-11 12:00:02

A strong product pipeline and increased group sales confirm that Roche is on the right growth path. By Andrew Humphreys

3 min read 2022-09-10 05:02:51

If you use insulin to manage your diabetes or are a caregiver for someone who does, you’ve likely noticed rising insulin prices in recent

3 min read 2022-09-07 00:34:34

Not many new insulin products have come to market in recent years, but that may be changing thanks to a new category of medications that will offer

3 min read 2022-09-07 00:34:34

Not many new insulin products have come to market in recent years, but that may be changing thanks to a new category of medications that will offer

3 min read 2022-09-07 00:25:03

Newly approved insulins that are designed to work the same as existing brand name insulins are a fast-growing segment of the insulin market,

3 min read 2022-09-07 00:25:03

Newly approved insulins that are designed to work the same as existing brand name insulins are a fast-growing segment of the insulin market,

6 min read 2022-08-27 08:22:00

My readers may recall that I disclosed (see my post at https://blog.sstrumello.com/2022/07/novartis-sandoz-is-back-in-insulin.html for details)

3 min read 2022-08-26 12:11:34

Analysis: Novartis CEO may struggle to rally investors to Sandoz spin-off By Natalie Grover LONDON, Aug 26 (Reuters) – Novartis CEO Vas Narasimhan

2 min read 2022-08-25 22:41:56

Novartis to spin off generics business Sandoz next year By Natalie Grover ZURICH/LONDON, Aug 25 (Reuters) – Novartis (NOVN.S) plans to spin off its

3 min read 2022-07-25 22:50:55

FDA hands out regulatory nods to Novartis, AstraZeneca, HOOKIPA Published: Jul 25, 2022 By Tristan Manalac BioSpace On Monday, the high-profile

6 min read 2022-07-22 23:40:00

Back in December 2018, the Sandoz division of Swiss pharmaceutical giant Novartis announced (see the full announcement HERE) "Sandoz enters into